IN2012DN02876A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02876A IN2012DN02876A IN2876DEN2012A IN2012DN02876A IN 2012DN02876 A IN2012DN02876 A IN 2012DN02876A IN 2876DEN2012 A IN2876DEN2012 A IN 2876DEN2012A IN 2012DN02876 A IN2012DN02876 A IN 2012DN02876A
- Authority
- IN
- India
- Prior art keywords
- compounds
- coupled receptor
- protein coupled
- modulate
- modulating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24946509P | 2009-10-07 | 2009-10-07 | |
PCT/US2010/051572 WO2011044195A1 (en) | 2009-10-07 | 2010-10-06 | Modulators of g protein-coupled receptor 88 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN02876A true IN2012DN02876A (es) | 2015-07-24 |
Family
ID=43480829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2876DEN2012 IN2012DN02876A (es) | 2009-10-07 | 2010-10-06 |
Country Status (7)
Country | Link |
---|---|
US (1) | US8497271B2 (es) |
EP (1) | EP2486030B1 (es) |
JP (1) | JP2013507369A (es) |
CN (1) | CN102686575A (es) |
ES (1) | ES2428492T3 (es) |
IN (1) | IN2012DN02876A (es) |
WO (1) | WO2011044195A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8304577B2 (en) | 2009-10-09 | 2012-11-06 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
US8426414B2 (en) | 2009-10-09 | 2013-04-23 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
US8598213B2 (en) | 2011-07-08 | 2013-12-03 | H. Lundbeck A/S | Positive allosteric modulators of nicotinic acetylcholine receptor |
UA111746C2 (uk) * | 2011-07-08 | 2016-06-10 | Х. Луннбек А/С | Позитивні алостеричні модулятори нікотинового рецептора ацетилхоліну |
US8703953B2 (en) | 2012-03-09 | 2014-04-22 | Bristol-Myers Squibb Company | Aryl ether-base kinase inhibitors |
WO2014006120A1 (en) * | 2012-07-06 | 2014-01-09 | H. Lundbeck A/S | New positive allosteric modulators of nicotinic acetylcholine receptor |
US20150315130A1 (en) * | 2012-12-10 | 2015-11-05 | H. Lundbeck A/S | New positive allosteric modulators of nicotinic acetylcholine receptor |
EP3019475A1 (en) | 2013-07-08 | 2016-05-18 | Bristol-Myers Squibb Company | Aryl amide kinase inhibitors |
JP6473146B2 (ja) | 2013-10-11 | 2019-02-20 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | ピロロトリアジンキナーゼ阻害剤 |
CN113005089A (zh) * | 2019-12-20 | 2021-06-22 | 泰州医药城国科化物生物医药科技有限公司 | 一种无标记细胞膜受体gpr88的细胞筛选模型及应用 |
CN111592531B (zh) * | 2020-06-23 | 2023-08-15 | 上海鲲博玖瑞医药科技发展有限公司 | 福瑞塞替的制备方法 |
GB202209193D0 (en) | 2022-06-22 | 2022-08-10 | Pandeia Therapeutics Ltd | Modulators of g protein-coupled receptor 88 |
GB202209195D0 (en) | 2022-06-22 | 2022-08-10 | Pandeia Therapeutics Ltd | Modulators of g protein-coupled receptor 88 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ141795A3 (en) | 1992-12-02 | 1995-11-15 | Pfizer | 4-substituted catechol diethers as such and for treating diseases and pharmaceutical preparations based thereon |
US5709861A (en) | 1993-04-22 | 1998-01-20 | Emisphere Technologies, Inc. | Compositions for the delivery of antigens |
JP2002527414A (ja) * | 1998-10-14 | 2002-08-27 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 1,2−ジ置換シクロプロパン |
EP1495009B1 (en) | 2002-04-05 | 2008-03-12 | Boehringer Ingelheim Pharmaceuticals Inc. | Cyanamides useful as reversible inhibitors of cysteine proteases |
WO2003103666A2 (en) | 2002-06-07 | 2003-12-18 | Altana Pharma Ag | Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones |
WO2004047738A2 (en) | 2002-11-22 | 2004-06-10 | Bristol-Myers Squibb Company | Arylcyclopropylcarboxylic amides as potassium channel openers |
WO2004056744A1 (en) | 2002-12-23 | 2004-07-08 | Janssen Pharmaceutica N.V. | Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
WO2004072018A1 (ja) | 2003-02-12 | 2004-08-26 | Takeda Pharmaceutical Company Limited | アミン誘導体 |
WO2005000309A2 (en) | 2003-06-27 | 2005-01-06 | Ionix Pharmaceuticals Limited | Chemical compounds |
US7834013B2 (en) * | 2003-11-19 | 2010-11-16 | Glaxosmithkline Llc | Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40 |
US20050288338A1 (en) | 2004-06-24 | 2005-12-29 | Wenqing Yao | Amido compounds and their use as pharmaceuticals |
CA2577610A1 (en) | 2004-09-10 | 2006-03-16 | Ucb Pharma, Sa | Sigma receptor ligands |
CN101160285A (zh) * | 2005-03-17 | 2008-04-09 | 辉瑞大药厂 | 适用于治疗疼痛的n-(n-磺酰氨基甲基)环丙烷甲酰胺衍生物 |
CN100494167C (zh) | 2005-08-02 | 2009-06-03 | 天津大学 | 抗乙肝病毒的叔胺氧化物及制备方法和制备药物的应用 |
JP2007217408A (ja) | 2006-01-19 | 2007-08-30 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
DK3091011T3 (en) | 2006-04-07 | 2018-02-26 | Vertex Pharma | MODULATORS OF ATP BINDING CASSETTE TRANSPORT |
WO2007129188A1 (en) | 2006-05-10 | 2007-11-15 | Pfizer Japan Inc. | Cyclopropanecarboxamide compound |
US20080040819A1 (en) | 2006-08-14 | 2008-02-14 | Wyeth | Methods of identifying agents for treatment of schizophrenia and related disorders |
US8304577B2 (en) | 2009-10-09 | 2012-11-06 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
US8426414B2 (en) | 2009-10-09 | 2013-04-23 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
-
2010
- 2010-10-01 US US12/895,916 patent/US8497271B2/en active Active
- 2010-10-06 WO PCT/US2010/051572 patent/WO2011044195A1/en active Application Filing
- 2010-10-06 ES ES10765715T patent/ES2428492T3/es active Active
- 2010-10-06 JP JP2012533264A patent/JP2013507369A/ja not_active Withdrawn
- 2010-10-06 CN CN2010800552740A patent/CN102686575A/zh active Pending
- 2010-10-06 IN IN2876DEN2012 patent/IN2012DN02876A/en unknown
- 2010-10-06 EP EP10765715.7A patent/EP2486030B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
CN102686575A (zh) | 2012-09-19 |
US20110245264A1 (en) | 2011-10-06 |
JP2013507369A (ja) | 2013-03-04 |
EP2486030A1 (en) | 2012-08-15 |
US8497271B2 (en) | 2013-07-30 |
WO2011044195A1 (en) | 2011-04-14 |
EP2486030B1 (en) | 2013-07-24 |
ES2428492T3 (es) | 2013-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN02876A (es) | ||
NZ612380A (en) | Modulators of toll-like receptors | |
PH12016501389A1 (en) | S1p modulating agent | |
PH12015501720A1 (en) | Modulators of methyl modifying enzymes, compositions and uses thereof | |
TN2010000062A1 (en) | Pyrrolidin -2-one derivatives as androgen receptor modulator | |
MY172156A (en) | Modulators of methyl modifying enzymes, compositions and uses thereof | |
AU2011232516A8 (en) | Chemical compounds | |
TN2011000639A1 (en) | Compounds which selectively modulate the cb2 receptor | |
IN2012DN02580A (es) | ||
MA32877B1 (fr) | Composes organiques | |
MX2011008602A (es) | Metodos de tratamiento de condiciones relacionadas con el cabello. | |
MX2009007336A (es) | Indazoles substituidos con 5-furopiridinona. | |
IL210446A0 (en) | Piperazine derivatives used as cav2.2 calcium channel modulators | |
UA107476C2 (uk) | Фармацевтична субстанція на основі мітохондріально адресованих антиоксидантів | |
WO2010057088A3 (en) | Pyrrolidinyl modulators of nicotinic acetylcholine receptors | |
TN2013000201A1 (en) | Methods and compositions for drying coal | |
HK1124842A1 (en) | Methods of preparing imidazole-based compounds | |
WO2009154739A3 (en) | Smoothened receptor modulators | |
MY151180A (en) | Electrocoating composition comprising a crater control additive | |
HK1259248A1 (zh) | 作為趨化因子受體調節劑的新的1,2-雙-磺醯胺衍生物 | |
MX337106B (es) | Antagonistas no competitivos de receptores nicotinicos. | |
WO2010060070A3 (en) | Indolinone modulators of dopamine receptor | |
UA101624C2 (ru) | Производные пирролидин-2-она как модуляторы рецептора андрогена | |
UA49630U (ru) | СОСТАВ Поверхностно-активнОГО вещества ДЛЯ ФОРМИРОВАНИЯ Износостойких Покрытий | |
UA74358U (en) | Phytotea composition |